
The latest trials of the potentially blockbuster new heart drug alirocumab show it lowers cholesterol in people at moderate and …

GSK has said its investigational chronic coronary heart disease pill darapladib has failed to meet its primary endpoint in a …
Researchers have warned of a lack of evidence to support prescribing statins in patients at low risk of developing heart …
A new statin has been launched in the UK by Japanese pharma company Kowa.Livazo (pitavastatin) has been approved by the …
New trials of a daily polypill – combining aspirin, a statin and two blood pressure lowering medicines – are underway …

AstraZeneca’s statin treatment Crestor has been approved in the European Union for the prevention of major cardiovascular events in patients …